C. Ravaglia (Castelbolognese, Italy), E. Renzoni (London, United Kingdom), R. Kaarteenaho-Wiik (Oulu, Finland), M. Vasakova (Prague, Czech Republic)
IPFdatabase – A new tool for a correct application of idiopathic pulmonary fibrosis guidelines
D. Bennett, M. L. Valentini, D. Valecchi, E. Bargagli, M. A. Mazzei, G. Bettini, C. Rinaldi, S. Pipavath, G. Raghu, P. Rottoli (Siena, Italy; Seattle, United States Of America)
|  |
Loss of PTEN induced lung fibroblasts exhibiting similar pathogenic features to cancer cells in idiopathic pulmonary fibrosis
J. Geng, X. Huang, H. Dai (Beijing, China)
|  |
Recent improvement of survival of acute exacerbation in idiopathic interstitial pneumonias: 10 years experience
T. Arai, Y. Inoue, C. Sugimoto, K. Tachibana, Y. Inoue, T. Kagawa, T. Okuma, M. Akira, M. Kitaichi, S. Hayashi (Sakai, Osaka, Japan)
| |
Macrophage polarization in interstitial lung diseases
P. Wojtan, M. Mierzejewski, I. Osinska, J. Domagala-Kulawik (Warsaw, Poland)
| |
Clinical spectrum of adult bronchiolitis – An eleven years retrospective analysis
P. Matos, D. Madama, M. J. Matos, L. Carvalho (Coimbra, Portugal)
| |
High resolution computed tomography (HRCT) can differentiate rapid from slow progressing Idiopathic pulmonary fibrosis (IPF)
E. Balestro, G. Turato, R. Polverosi, G. Barbiero, S. Zagallo, A. Floriani, F. Rea, F. Calabrese, E. Bazzan, M. Schiavon, N. Nannini, S. Baraldo, M. Saetta, M. Cosio (Padova, San Dona', Italy)
| |
Prognostic influence of comorbidities in idiopathic pulmonary fibrosis (IPF)
S. Ehlers-Tenenbaum, U. Oltmanns, K. Palmowski, T. Muley, M. Schaaf, A. Warth, P. A. Schnabel, C. P. Heussel, F. J. F. Herth, M. Kreuter (Heidelberg, Germany)
| |
Lymphopoenia and pneumocystis jiroveci (PCP) prophylaxis experience in non-specific interstitial pneumonitis (NSIP)
S. Gudur, P. Newton, C. Leonard, N. Chaudhuri (Manchester, United Kingdom)
| |
Six-minute walk test desaturation and echocardiographic findings in IPF: Correlational observations made in the European IPF registry (eurIPFreg)
A. Guenther, F. Drakopanagiotakis, C. Vancheri, P. Bonniaud, A. Wells, B. Crestani (Giessen, Germany; Catania, Italy; Dijon, Paris, France; London, United Kingdom)
| |
Intraindividual response to treatment with pirfenidone in two independent European IPF cohorts
B. Loeh, F. Drakopanagiotakis, G. P. Bandelli, E. Cordani, S. Tello, D. von der Beck, W. Seeger, P. Markart, A. Guenther, C. Albera (Giessen, Germany; Torino, Italy)
| |
Effect of pirfenidone on TGF-beta-induced pro-fibrotic effects in primary human lung cells derived from patients with idiopathic pulmonary fibrosis
K. Hostettler, J. Zhong, M. Tamm, D. Lardinois, M. Roth (Basel, Switzerland)
| |
Pirfenidone suppresses proinflammatory and antiangiogenetic cytokine production by alveolar macrophages (AMs) in idiopathic non specific interstitial pneumonia (iNSIP)
X. He, X. Long, T. E. Wessendorf, D. Theegarten, J. Guzman, U. Costabel, F. Bonella (Essen, Bochum, Germany)
| |
Transient elastography detection of early liver fibrosis in idiopathic pulmonary fibrosis patients
A. Sanduzzi, M. Bocchino, G. Brancaccio, M. De Martino, G. Rea, A. Capaccio, G. B. Gaeta (Naples, Italy)
| |
Desquamative interstitial pneumonia in a Danish cohort, treatment response and outcome
C. Hyldgaard, E. Bendstrup, O. Hilberg (Aarhus, Denmark)
| |
Expression phenotypes of CD4+ and CD8+ T lymphocytes in bronchoalveolar lavage fluid and blood in lung fibrosis
M. Vasakova, M. Sterclova, P. Paluch, V. Polcova, P. Mandakova, M. Paulik, K. Ziad (Prague, Czech Republic)
| |
Clinical course and outcome of vasculitis related interstitial lung disease
B. Y. Lee, S. M. Lee, J. S. Song, J. W. Song (Seoul, Republic Of Korea)
| |
Usefulness of bronchoalveolar lavage in the diagnosis of desquamative interstitial pneumonia
T. Wessendorf, F. Bonella, D. Theegarten, U. Costabel (Essen, Germany)
| |
Description of a murine model of acute pneumonitis hypersensitivity to pigeon serum
M. Sánchez Ortiz, X. Muñoz, S. Gómez Ollés, M. D. Untoria Corral, F. Morell Brotad, M. J. Cruz (Barcelona, Madrid, Spain)
| |
Translation and validation of the King's brief interstitial lung disease (K-BILD) questionnaire in French, Italian and Dutch
M. Wapenaar, A. S. Patel, S. S. Birring, V. Cottin, C. Vancheri, R. T. Van Domburg, E. W. P. Bakker, M. S. Wijsenbeek (Rotterdam, Amsterdam, Netherlands; London, United Kingdom; Lyon, France; Catania, Italy)
| |
Surfactant protein B proforms as potential new biomarkers for idiopathic pulmonary fibrosis
C. Ruppert, L. Hirschbach, H. Nef, W. Seeger, A. Guenther, P. Markart (Giessen, Germany)
| |